Company intelligence / Profile preview

Surglasses

Taichung, Taichung City, Taiwansurglasses.com ↗

Ownership: Private
Development stage: Other

Overview

Surglasses has developed the FDA-cleared Caduceus S AR Spine Navigation System, which enables real-time augmented reality guidance for spine surgeries. The system has been successfully used in clinical settings in the US and Asia to improve precision and outcomes. Their Asclepius Virtual Dissection Table supports advanced medical education.

Therapeutic areas: NeurologyOther
Modalities: Device (Augmented reality surgical navigation system)Non-pharmacological therapy (Medical education tools)
Industry: Surgical Medical Devices

Partnerships

Central Taiwan Science Park collaboration on Precision Health Programpartnerships with hospitals such as Stevenson Surgery Center (US)Thailand Veterans General HospitalChulalongkorn Hospital

Beyond the preview

Go deeper on Surglasses.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Surglasses.

Explore the full profile